...
首页> 外文期刊>Journal of Bioscience and Bioengineering >Production of Recombinant Human Lysosomal Acid Lipase in Schizosaccharomyces pombe:Development of a Fed-Batch Fermentation and Purification Process
【24h】

Production of Recombinant Human Lysosomal Acid Lipase in Schizosaccharomyces pombe:Development of a Fed-Batch Fermentation and Purification Process

机译:粟酒裂殖酵母中重组人溶酶体酸性脂肪酶的生产:补料分批发酵和纯化工艺的发展

获取原文
获取原文并翻译 | 示例
           

摘要

A fed-batch fermentation process has been developed to enable the production of large quantities of recombinant human lysosomal acid lipase(hLAL;EC 3.1.1.13),in Schizosaccharomyces pombe,for preclinical studies as a potential enzyme therapy drug.Recombinant S.pombe,clone ASP397-21,expressed enzymatically active hLAL in the secreted form.A feedback fed-batch system was used to determine the optimal feed rate of a 50% glucose solution used as the carbon source.The feed rate of the glucose solution was calculated by a computer-aided system according to the equation;F=q_(sf)(VX)/S_(in)specific substrate feed rate gram substrate/gram dry cell weight/h;V,volume of culture broth l;X,cell density gram dry cell weight/l;S_(in),concentration of growth limiting substrate in feed solution gram substrate/gram feed solution).At the time of the initial consumption of glucose in the batch-phase culture,the nutrient supply was automatically initiated by means of monitoring the respiratory quotient change.The obtained profile of the feed rate was applied to the feed forward control fermentation.Finally,the cells were grown up to >50 g dry cell weight/l,and the hLAL expression level was approximately 16,000 V/l.Expressed hLAL protein was purified in a two-step process by hydrophobic interaction and anion exchange chromatographies.Purified recombinant hLAL exhibited a 90-150 kDa broad band upon SDS-PAGE with specific activity of about 300 U/mg.After endoglycosidase H treatment,the band converged to 45 kDa,equal to the calculated molecular weight,suggesting that hLAL produced in S.pombe was hyper-glycosylated.N-terminal analysis of de-glycosylated hLAL revealed that the signal sequence of hLAL was correctly processed in S.pombe.
机译:已经开发了分批补料发酵工艺,以能够在粟酒裂殖酵母中生产大量重组人溶酶体酸性脂肪酶(hLAL; EC 3.1.1.13),作为潜在的酶治疗药物进行临床前研究。重组粟酒裂殖酵母,克隆ASP397-21,以分泌形式表达酶促活性hLAL。使用反馈补料分批系统确定50%葡萄糖溶液作为碳源的最佳进料速率。 F = q_(sf)(VX)/ S_(in)特定底物进料量克底物/克干细胞重量/ h; V,培养液体积l; X,细胞密度克干细胞重量/ l; S_(in),饲料溶液中生长限制底物的浓度克(克基质/克饲料)。在分批阶段培养物中最初消耗葡萄糖时,自动开始营养供应通过监测呼吸商ge。将获得的进料速度曲线应用于前馈对照发酵。最后,细胞生长至> 50 g干细胞重量/ l,hLAL表达水平约为16,000 V / l。经疏水相互作用和阴离子交换色谱法分两步纯化。纯化的重组hLAL经SDS-PAGE显示90-150 kDa宽条带,比活性约为300 U / mg。经糖苷内切酶H处理后,该条带收敛至45 kDa,等于计算的分子量,表明在粟酒裂殖酵母中产生的hLAL被高度糖基化。去糖基化的hLAL的N端分析表明,hLAL的信号序列已在粟酒裂殖酵母中正确处理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号